PPARgamma-Mediated and Arachidonic Acid-Dependent Signaling is Involved in Differentiation and Lipid Production of Human Sebocytes.

Dozsa, A. and Dezső, Balázs and Tóth, Balázs István and Bácsi, Attila and Póliska, Szilárd and Bíró, Tamás and Rühl, Ralph and Remenyik, Éva and Nagy, László (2014) PPARgamma-Mediated and Arachidonic Acid-Dependent Signaling is Involved in Differentiation and Lipid Production of Human Sebocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134 (4). pp. 910-920. ISSN 0022-202X

Text JInvestDermatol_134_910.pdf Restricted to Repository staff only Download (3MB) | Request a copy

Abstract

The transcriptional basis of sebocyte differentiation and lipid production is mostly unclear. Peroxisome proliferator-activated receptor gamma (PPARgamma), a lipid activated transcription factor, has been implicated in differentiation and lipid metabolism of various cell types. Here, we show that PPARgamma is differentially expressed in normal and pathological human sebocytes, and appears to have roles in their differentiation and lipid production. We used laser microdissected normal and pathologic human sebaceous glands (SG) and SZ95 cells (immortalized sebocyte cell line) analyzed by RT-qPCR and immunohistochemistry. Lipids were analyzed by quantitative fluorimetry and mass spectrometry based approaches. We have observed that PPARgamma and its target genes, ADRP and PGAR, are expressed in sebocytes and show association with their level of differentiation. Also, PPARgamma is present in normal and hyperplastic SG, whereas its expression levels are decreased in SG adenoma and SG carcinoma cells, reflecting a maturation-linked expression pattern. Furthermore, in SZ95 sebocytes, naturally occurring lipids including arachidonic acid and arachidonic acid keto-metabolites (eg 5-KETE, 12-KETE) appear to regulate PPARgamma signaling pathways, which in turn modulate phospholipid biosynthesis and induce neutral lipid synthesis. Collectively, our findings highlight the importance of endogenous ligand-activated PPARgamma signaling in human sebocyte biology and suggest that PPARgamma might be a promising candidate for the clinical management of SG disorders.Journal of Investigative Dermatology accepted article preview online, 15 October 2013; doi:10.1038/jid.2013.413.

Actions (login required)

Edit Item